WHO ICTRP trial
Influence of Valsartan or Olmesartan on renin-angiotensin-aldosterone system and…
JPRN-UMIN000003518 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003518 |
|---|---|
| Public title | Influence of Valsartan or Olmesartan on renin-angiotensin-aldosterone system and cardiac muscle |
| Scientific title | Influence of Valsartan or Olmesartan on renin-angiotensin-aldosterone system and cardiac muscle - Influence of Valsartan or Olmesartan on renin-angiotensin-aldosterone system and cardiac muscle |
| Primary sponsor | Nihon University School of Medicine |
| Secondary sponsors | Sekino Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Hypertension after cardiac surgery |
| Interventions | Switch from Candesartan to Olmesartan |
| Registration date | Apr 22, 2010 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: